( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults.

The man who hopes to be President Donald Trump’s health secretary repeatedly asked to see “data” or “science” showing ...

Kennedy Jr. earned more than $2.4 million as a consultant referring cases to the law firm Wisner Baum, government records show. Wisner Baum is suing Merck & Co. over allegations that the ...

Although there are no human cases of avian flu in Massachusetts, officials this week advised poultry farmers and people with ...

Bird flu is now believed to be widespread in Massachusetts and is likely present even in places where there has not been a ...